论文部分内容阅读
目的评价葛酮通络胶囊联合脑循环理疗仪治疗脑梗塞恢复期临床症状的安全性及有效性。方法采用随机、对照、多中心研究方法收纳100例脑梗塞恢复期患者。设为对照组、治疗组;两组常规治疗方案中均以血塞通、脑苷肌肽为基础用药,辅以脑循环康复理疗;治疗组加用葛酮通络胶囊口服,每次2粒,每日两次,连服7天,共服2个疗程,治疗28 d后,观察并评价其临床疗效和安全性。结果两组治疗脑梗塞后遗症状均有明显疗效;组间比较,治疗组明显优于对照组,具有统计学意义(P<0.05);且2组观察治疗中均未出现不良事件;结论葛酮通络胶囊联合脑循环理疗改善脑梗塞恢复期症状,安全有效。
Objective To evaluate the safety and efficacy of Puerarin-Tongluo Capsule combined with cerebral circulation physiotherapy instrument in the treatment of clinical symptoms of cerebral infarction. Methods A randomized, controlled, multicenter study was performed to receive 100 patients with convalescent cerebral infarction. As the control group, treatment group; two conventional treatment programs are Xuesaitong, cerebroside-based medication, supplemented by cerebral circulation rehabilitation therapy; treatment group with orally administered Ketong Tongluo capsules, each 2, Twice daily for 7 consecutive days for a total of 2 courses of treatment. After 28 days of treatment, the clinical efficacy and safety were observed and evaluated. Results Both groups had obvious curative effect in treating sequelae of cerebral infarction. Compared with the control group, the treatment group was significantly better than the control group (P <0.05), and no adverse events were observed in the two groups. Tongluo capsule combined with cerebral circulation therapy to improve recovery symptoms of cerebral infarction, safe and effective.